1. Home
  2. CDIO vs PMD Comparison

CDIO vs PMD Comparison

Compare CDIO & PMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • PMD
  • Stock Information
  • Founded
  • CDIO 2017
  • PMD 1986
  • Country
  • CDIO United States
  • PMD United States
  • Employees
  • CDIO N/A
  • PMD N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • PMD Medical Specialities
  • Sector
  • CDIO Health Care
  • PMD Health Care
  • Exchange
  • CDIO Nasdaq
  • PMD Nasdaq
  • Market Cap
  • CDIO 12.4M
  • PMD 13.7M
  • IPO Year
  • CDIO N/A
  • PMD N/A
  • Fundamental
  • Price
  • CDIO $0.26
  • PMD $2.35
  • Analyst Decision
  • CDIO Buy
  • PMD
  • Analyst Count
  • CDIO 1
  • PMD 0
  • Target Price
  • CDIO $2.00
  • PMD N/A
  • AVG Volume (30 Days)
  • CDIO 5.4M
  • PMD 23.9K
  • Earning Date
  • CDIO 11-13-2024
  • PMD 11-12-2024
  • Dividend Yield
  • CDIO N/A
  • PMD N/A
  • EPS Growth
  • CDIO N/A
  • PMD N/A
  • EPS
  • CDIO N/A
  • PMD N/A
  • Revenue
  • CDIO $39,138.00
  • PMD $20,258,000.00
  • Revenue This Year
  • CDIO $2,093.61
  • PMD N/A
  • Revenue Next Year
  • CDIO $43.05
  • PMD N/A
  • P/E Ratio
  • CDIO N/A
  • PMD N/A
  • Revenue Growth
  • CDIO 1363.10
  • PMD N/A
  • 52 Week Low
  • CDIO $0.19
  • PMD $1.63
  • 52 Week High
  • CDIO $3.56
  • PMD $3.93
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 45.30
  • PMD 56.93
  • Support Level
  • CDIO $0.21
  • PMD $2.31
  • Resistance Level
  • CDIO $0.52
  • PMD $2.35
  • Average True Range (ATR)
  • CDIO 0.06
  • PMD 0.02
  • MACD
  • CDIO -0.00
  • PMD 0.00
  • Stochastic Oscillator
  • CDIO 6.27
  • PMD 87.50

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

About PMD Psychemedics Corporation

Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.

Share on Social Networks: